↓ Skip to main content
What is this page? Embed badge

A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-160…

Overview of attention for article published in Journal of Thoracic Oncology, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
2 X users
patent
1 patent
facebook
1 Facebook page
guideline
2 clinical guideline sources

Readers on

mendeley
97 Mendeley